Biotech Business - October 10, 2023
Cellevate raises 39 million SEK
Cellevate has announced the closure of its recent investment round, securing a total of 39 million SEK. The round was led by Industrifonden, in syndication with the European Innovation Council Fund (EIC Fund) and Onsight Ventures. “We are thrilled to have gained tremendous support from such a strong syndicate of investors, who share our vision […]
Biotech Business - September 27, 2023
Abera collaborates with strategic investors and executes a directed share issue
Abera Bioscience begins cooperation with three strategic investors and in connection with this, the board has decided to carry out a directed new share issue of 1,555,556 shares at a subscription price of SEK 3.60 per share, which adds to the company SEK 5.6 million before issue costs. The three strategic investors are Gunnar Sachs […]
Financing - September 27, 2023
Iconovo carries out a directed share issue of SEK 19.2 million
The company carries out a directed share issue to a limited number of current shareholders in the company, such as Gerald Engström who, following the Share Issue, becomes the largest shareholder. In addition, Andra AP-Fonden, Humle Fonder, Cicero Fonder, as well as the member of the Board of Directors, and until now the largest shareholder, […]
Biotech Business - September 13, 2023
Lauxera Capital Partners invests 17 million EUR in BioLamina
With the investment, Lauxera Capital Partners is joining with other investors, majority owner Bure Equity AB and Northislet AB, as well as with BioLamina’s founders and executives as shareholders in support of the company’s mission. “The BioLamina team is excited to welcome Lauxera to our committed group of shareholders and to our Board of Directors, […]
Biotech Business - September 4, 2023
Pfizer invests another quarter of a billion SEK in the Strängnäs facility
The investment, in the form of an expansion, is a capacity-enhancing measure in the facility that creates space to produce more drugs and vaccines. Prior to the opening of the multi-production facility in 2009, Pfizer invested 1.5 billion SEK and has since made several investments of over half a billion kroner to expand production capacity […]
Agreement - August 9, 2023
Evaxion announces financing commitments totaling up to 20 MUSD
Evaxion Biotech has entered into a binding agreement for a financing of up to 20 million USD with Negma Group Investment. “We are pleased to be able to establish a flexible financing vehicle with Negma Group. The ability to attract such an experienced investor is a tribute to Evaxion’s AI technology and pipeline progress,” says […]
